logo

Emergent Biosolutions Inc (EBS) Stock: A Year of Highs and Lows in the Market

AMZN

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Emergent Biosolutions Inc’s current trading price is -81.32% away from its 52-week high, while its distance from the 52-week low is 43.66%. The stock’s price range for this period has been between $1.42 and $10.92 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.94 million for the day, a number notably lower than the average daily volume of 2.99 million over the last three months.

Emergent Biosolutions Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $10.92 on 05/11/23, while the lowest price for the same period was registered at $1.42 on 02/06/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Emergent Biosolutions Inc (EBS) has experienced a quarterly rise of 11.48% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 106.49M and boasts a workforce of 1600 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.26, with a change in price of -0.05. Similarly, Emergent Biosolutions Inc recorded 2,416,114 in trading volume during the last 100 days, posting a change of -2.39%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for EBS stands at 1.35. Similarly, the long-term debt-to-equity ratio is also 0.71.

EBS Stock Stochastic Average

Emergent Biosolutions Inc’s raw stochastic average for the past 50 days is presently 25.11%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 24.49%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 10.05% and 5.65%, respectively.

EBS Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -15.00% this year. Over the last six months, there has been a stronger performance of -11.69%. The price of EBS leaped by -18.73% during the last 30 days period. For the last 5-days stocks have slided -0.97%.

Most Popular